retatrutide 6 weeks for weight loss: Study shows 30% body weight loss Retatrutide UK 2026: Phase 3

Recommend it highly.* Was this helpful

"These findings mirror the conversations we're having with customers," said James Wantuck, MD, Accolade associate chief medical officer

Some providers will prescribe below BMI 27 based on clinical judgment

Emphasizing the value of these incretin-based options for better understanding treatment mechanisms, she said she hopes additional options will emerge to offer benefits beyond weight loss and diabetes management, including disease-modifying effects

Are GLP-1s worth the investment for employers knowing that employees may leave before the long-term health and cost benefits are realized

10.1016/j.ajog.2024.08.024 Am J Obstet Gynecol